Shavit E, Marzano AV, Alavi A. Ulcerative versus non-ulcerative panniculitis: is it time for a novel clinical approach to panniculitis? Int J Dermatol. 2021;60(4):407–17.

Article  Google Scholar 

Velter C, Lipsker D. Cutaneous panniculitis [in French]. Rev Med Interne. 2016;37(11):743–50.

CAS  Article  Google Scholar 

Durosaro O, Davis MD, Reed KB, Rohlinger AL. Incidence of cutaneous lupus erythematosus, 1965–2005: a population-based study. Arch Dermatol. 2009;145(3):249–53.

Article  Google Scholar 

Blake T, Manahan M, Rodins K. Erythema nodosum: a review of an uncommon panniculitis. Dermatol Online J. 2014;20(4):22376.

Article  Google Scholar 

Wick MR. Panniculitis: a summary. Semin Diagn Pathol. 2017;34(3):261–72.

Article  Google Scholar 

Borroni G, Giorgini C, Tomasini C, Brazzelli V. How to make a specific diagnosis of panniculitis on clinical grounds alone: an integrated pathway of general criteria and specific findings. G Ital Dermatol Venereol. 2013;148(4):325–33.

CAS  PubMed  Google Scholar 

Requena L. Normal subcutaneous fat, necrosis of adipocytes and classification of the panniculitides. Semin Cutan Med Surg. 2007;26(2):66–70.

CAS  Article  Google Scholar 

Requena L. Panniculitis. Philadelphia: Saunders; 2008.

Google Scholar 

Morrison LK, Rapini R, Willison CB, Tyring S. Infection and panniculitis. Dermatol Ther. 2010;23(4):328–40.

Article  Google Scholar 

Leung AKC, Leong KF, Lam JM. Erythema nodosum. World J Pediatr. 2018;14(6):548–54.

Article  Google Scholar 

Filotico R, Mastrandrea V. Cutaneous lupus erythematosus: clinico-pathologic correlation. G Ital Dermatol Venereol. 2018;153(2):216–29.

PubMed  Google Scholar 

Fraga J, Garcia-Diez A. Lupus erythematosus panniculitis. Dermatol Clin. 2008;26(4):453–63.

Article  Google Scholar 

Hansen CB, Callen JP. Connective tissue panniculitis: lupus panniculitis, dermatomyositis, morphea/scleroderma. Dermatol Ther. 2010;23(4):341–9.

Article  Google Scholar 

Herrerin CL, et al. El lupus paniculitis: una paniculitis mixta. 1987.

Martens PB, Moder KG, Ahmed I. Lupus panniculitis: clinical perspectives from a case series. J Rheumatol. 1999;26(1):68–72.

CAS  PubMed  Google Scholar 

Requena L, Sanchez Yus E. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol. 2001;45(3):325–61.

Bonkemeyer Millan S, Gan R, Townsend PE. Venous ulcers: diagnosis and treatment. Am Fam Physician. 2019;100(5):298–305.

PubMed  Google Scholar 

Alavi A, Sibbald RG, Phillips TJ, Miller OF, Margolis DJ, Marston W, et al. What’s new: management of venous leg ulcers: approach to venous leg ulcers. J Am Acad Dermatol. 2016;74(4):627–40.

Article  Google Scholar 

Miteva M, Romanelli P, Kirsner RS. Lipodermatosclerosis. Dermatol Ther. 2010;23(4):375–88.

Article  Google Scholar 

Chan MP. Neutrophilic panniculitis: algorithmic approach to a heterogeneous group of disorders. Arch Pathol Lab Med. 2014;138(10):1337–43.

Article  Google Scholar 

Llamas-Velasco M, Fraga J, Sanchez-Schmidt JM, Fernandez-Figueras M, Gallardo F, Rutten A, et al. Neutrophilic infiltrates in panniculitis: comprehensive review and diagnostic algorithm proposal. Am J Dermatopathol. 2020;42(10):717–30.

Article  Google Scholar 

Takeshita M, Imayama S, Oshiro Y, Kurihara K, Okamoto S, Matsuki Y, et al. Clinicopathologic analysis of 22 cases of subcutaneous panniculitis-like CD56- or CD56+ lymphoma and review of 44 other reported cases. Am J Clin Pathol. 2004;121(3):408–16.

Article  Google Scholar 

Baxi KD, Rathod SP, Chaudhary RG, Jagati A. Subcutaneous panniculitis-like T-cell lymphoma. Indian J Dermatol Venereol Leprol. 2020;86(5):606.

PubMed  Google Scholar 

Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. 2008;111(2):838–45.

CAS  Article  Google Scholar 

Mazhar AR, Johnson RJ, Gillen D, Stivelman JC, Ryan MJ, Davis CL, et al. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int. 2001;60(1):324–32.

CAS  Article  Google Scholar 

Choy B, Chou S, Anforth R, Fernandez-Penas P. Panniculitis in patients treated with BRAF inhibitors: a case series. Am J Dermatopathol. 2014;36(6):493–7.

Article  Google Scholar 

Vazquez-Osorio I, Sanchez-Aguilar MD, Garcia-Rodino S, Suarez-Penaranda JM, Aliste C, Vazquez-Veiga H. Vemurafenib-induced neutrophilic panniculitis: a new case and review of the literature. Am J Dermatopathol. 2016;38(7):e93–6.

Article  Google Scholar 

Finelt N, Lulla RR, Melin-Aldana H, Ruth JS, Lin FY, Su JM, et al. Bumps in the road: panniculitis in children and adolescents treated with vemurafenib. Pediatr Dermatol. 2017;34(3):337–41.

Article  Google Scholar 

Macdonald JB, Macdonald B, Golitz LE, LoRusso P, Sekulic A. Cutaneous adverse effects of targeted therapies: part II: inhibitors of intracellular molecular signaling pathways. J Am Acad Dermatol. 2015;72(2):221–36.

CAS  Article  Google Scholar 

Piroth M, Frenard C, Eugene-Lamer J, Dreno B, Quereux G. Panniculitis during BRAF inhibitor and/or MEK inhibitor therapy: a new case report and literature review [in French]. Ann Dermatol Venereol. 2020;147(12):833–41.

CAS  Article  Google Scholar 

Kismet E, Demirkaya E, Koseoglu V, Deveci S, Atay AA. Panniculitis induced by a chemotherapy regimen consisting of topotecan and cyclophosphamide. Pediatr Blood Cancer. 2005;44(1):98–9.

Article  Google Scholar 

Mohamednour A, Khan S, Sunmboye K, Kinder A. A rare case of anti-TNF induced panniculitis. Rheumatol Adv Pract. 2020;2020:4.

Google Scholar 

Lambert JLW, De Schepper S, Speeckaert R. Cutaneous manifestations in biological-treated inflammatory bowel disease patients: a narrative review. J Clin Med. 2021;10(5):1040.

CAS  Article  Google Scholar 

Mavrikakis I, Georgiadis T, Fragiadaki K, Sfikakis PP. Orbital lobular panniculitis in Weber-Christian disease: sustained response to anti-TNF treatment and review of the literature. Surv Ophthalmol. 2010;55(6):584–9.

Article  Google Scholar 

Antwi-Amoabeng D, Ghuman J, Ghuman J, Beutler BD, Ulanja MB, Kuriakose K, et al. Ponatinib-associated panniculitis: case report and review of the literature. Cancer Treat Res Commun. 2021;27: 100357.

Article  Google Scholar 

Sibaud V, Beylot-Barry M, Protin C, Vigarios E, Recher C, Ysebaert L. Dermatological toxicities of Bruton’s tyrosine kinase inhibitors. Am J Clin Dermatol. 2020;21(6):799–812.

Article  Google Scholar 

Borroni G, Torti S, D’Ospina RM, Pezzini C. Drug-induced panniculitides. G Ital Dermatol Venereol. 2014;149(2):263–70.

CAS  PubMed  Google Scholar 

Fabbro SK, Smith SM, Dubovsky JA, Gru AA, Jones JA. Panniculitis in patients undergoing treatment with the Bruton tyrosine kinase inhibitor ibrutinib for lymphoid leukemias. JAMA Oncol. 2015;1(5):684–6.

Article  Google Scholar 

Stewart J, Bayers S, Vandergriff T. Self-limiting ibrutinib-induced neutrophilic panniculitis. Am J Dermatopathol. 2018;40(2):e28–9.

Article  Google Scholar